Elevra Lithium Completes Sale of E45/2364 Pegmatite Rights
BRISBANE, Australia, Aug. 07, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (“Elevra” or "Company") (ASX:ELV; NASDAQ:ELVR) is pleased to announce that it has completed a transaction with Wildcat Resources Limited (“Wildcat”) regarding the Company’s rights, interests and obligations on E45/2364 in Western Australia (referred to as Tabba Tabba in Elevra exploration disclosure).
Covered in this story
What has happened since
- Elevance Health is up 11.7% since this was published, 74 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Elevance Health
- Guggenheim: $421 → $460 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ELV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Elevance Health →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.